New MainStream Capital
Also known as NMS Capital
A New York firm (often shortened to NMS Capital) investing $25M to $75M in healthcare and business services companies with $5M to $25M of EBITDA. Known for multi-site healthcare builds in dental, autism services, and specialty practices.
| Headquarters | New York, New York |
|---|---|
| Fund size / AUM | Fund III $450M (2019) |
| Check size / target EBITDA | EBITDA $5M-$25M at entry; equity $25M-$75M |
| Target company size | $15M-$40M EBITDA |
| Sector focus | Healthcare services (dental, autism, podiatry, urology, staffing) + business services |
| Strategy | Buyout and growth |
| Add-on acquisitions | Active add-on acquirer |
| Website | nms-capital.com |
Compiled from New MainStream Capital's website and public announcements. Numbers change as new funds close; treat this as a starting point, not a term sheet. Report a correction.
Selling to a firm like this?
Buyers like New MainStream Capital will test your numbers before they trust them.
Crawford McMillan gets mid-market companies diligence-ready: revenue you can trace, metrics you can defend, reporting that holds up in a data room. Free weekly brief on what buyers actually look for.
Get Inside the Data Room